Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

2.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-guided compound prioritization strategy for virtual screening identifies putative binders for the nuclear receptor LRH-1.

bioRxiv : the preprint server for biology·2026
Same author

Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

bioRxiv : the preprint server for biology·2026
Same author

The pathway-independent positive allosteric modulator C1 allows for the identification of active Y<sub>4</sub> receptor relevant positions.

Cellular and molecular life sciences : CMLS·2026
Same author

Superwater as a generative AI framework to predict water molecule positions on protein structures.

Communications chemistry·2025
Same author

Investigating the neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies.

Nature communications·2025
Same author

Classification models distinguish functional and trafficking effects of KCNQ1 variants to enhance variant interpretation.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Mar 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.

Jeffrey Mendenhall1, Jens Meiler2

  • 1Department of Chemistry, Center for Structural Biology, Institute of Chemical Biology, Vanderbilt University, 7330 Stevenson Center, Station B 351822, Nashville, TN, 37235, USA.

Journal of Computer-Aided Molecular Design
|February 3, 2016
PubMed
Summary
This summary is machine-generated.

Dropout, an Artificial Intelligence technique, enhances Artificial Neural Network (ANN) performance in drug discovery. This method significantly improves accuracy in Quantitative Structure-Activity Relationship (QSAR) modeling for drug design.

Keywords:
Artificial Neural Network (ANN)BioChemicalLibrary (BCL)DropoutLigand-Based Computer-Aided Drug Discovery (LB-CADD)Machine learning (ML)Quantitative Structure Activity Relationship (QSAR)

More Related Videos

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

5.6K

Related Experiment Videos

Last Updated: Mar 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention
06:37

Author Spotlight: Addressing Technical and Subjective Challenges in Measuring Classroom Attention

Published on: December 15, 2023

5.6K

Area of Science:

  • Computational chemistry
  • Machine learning
  • Drug discovery

Background:

  • Artificial Neural Networks (ANNs) are powerful machine learning tools.
  • Dropout is a known technique to improve ANN performance on standard datasets.
  • Quantitative Structure-Activity Relationship (QSAR) datasets present unique challenges for ANNs, including data bias and a high descriptor-to-active ratio.

Purpose of the Study:

  • To evaluate the effectiveness of dropout in improving ANN performance for QSAR modeling.
  • To benchmark dropout's impact on QSAR datasets within Ligand-Based Computer-Aided Drug Discovery.

Main Methods:

  • A benchmark study was conducted on nine large QSAR datasets.
  • Artificial Neural Networks (ANNs) were trained with and without the dropout technique.
  • Performance was assessed using metrics such as enrichment false positive rate and log-scaled area under the receiver-operating characteristic curve (logAUC).

Main Results:

  • Dropout significantly improved both enrichment false positive rate and logAUC by 22-46% compared to conventional ANN implementations.
  • Optimal dropout rates were identified as a function of the descriptor set's signal-to-noise ratio, showing independence from the specific dataset.
  • ANNs utilizing dropout with 2D and 3D autocorrelation descriptors outperformed standard ANNs and optimized fingerprint similarity search methods.

Conclusions:

  • Dropout is an effective technique for enhancing ANN performance in QSAR modeling for drug discovery.
  • The findings suggest that dropout can help overcome challenges posed by QSAR datasets, leading to more accurate predictions.
  • This study highlights the potential of dropout-enhanced ANNs as a valuable tool in Ligand-Based Computer-Aided Drug Discovery.